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Abstract
Objective: This study aims to investigate the in vitro effects of Ulinastatin (UTI) and Taxotere (TXT) on cell
proliferation; cell apoptosis; xenografted tumor growth; and expression of insulin-like growth factor receptor 1 (IGF-
1R), platelet-derived growth factor A (PDGFA), nerve growth factor (NGF), c-Jun N-terminal kinase 2 (JNk-2), and NF-
B in a human primary breast cancer cells and breast cancer cell line MDA-MB-231.
Methods: The cell lines cultured were divided into four groups: 1) control group, 2) UTI group, 3) TXT group, and
4) UTI+TXT group. The method of MTT essay, flow cytometry, and RT-PCR were used to detect cell proliferation,
cell apoptosis, and expression of IGF-1R, PDGFA, NGF, NF-B, JNk-2, respectively. The growth of xenografted tumor
in nude mice was used to calculate the anti-tumor rate. Immunohistochemistry staining (SP) was used to detect
the expression of IGF-1R, PDGFA, NGF, ki-67, caspase-3, JNk-2, and NF-B.
Results: Proliferation of human breast cancer cells and MDA-MB-231 cell lines, and growth rate of xenografted
tumor decreased in order of UTI+TXT > TXT > UTI > control, apoptosis increased in the order control < UTI < TXT
< UTI+TXT. The gene expression and protein expression of IGF-1R, PDGFA, NGF, NF-B and JNk-2 in breast cancer
cells was inhibited by UTI and TXT.
Conclusions: UTI 1) inhibits the proliferation of human breast cancer cells and the growth of xenografted tumors,
2) induces cancer cell apoptosis, and 3) enhances the anti-tumor effect of TXT. This mechanism might be related
to decreasing signal transduction of JNk-2 and NF-B, and then expression of IGF-1R, PDGFA, NGF.
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Introduction
Breast cancer is a major malignant tumor threatens
women’s health. It is the second leading cause to
women’s death [1]. Ulinastatin (UTI), a physiological
urinary trypsin inhibitor, inhibits a variety of proteases.
It is widely used in treatment of inflammatory diseases,
including disseminated intravascular coagulation, shock,
and pancreatitis [2,3]. Our previous study showed that
UTI exerts significant inhibitory effects on 1) the prolif-
eration and invasion of human breast cancer cell lines
MCF-7 and MDA-MB-231, 2) the growth of MCF-7
transplanted tumor in nude mice, 3) the gene and pro-
tein expression of CXCR4 and MMP-9 in breast cancer
cells; UTI also enhances the anti-tumor effect of the
chemotherapy drug cyclophosphamide [4,5]. TXT is the
most effective chemotherapy drug to treat breast cancer.
It is widely used on the treatment of metastatic breast
cancer. In addition, it is a novel adjuvant chemotherapy
for breast cancer patients [6]. In this study, we detected
the inhibitory mechanisms of UTI on breast carcinoma
growth via observations in in vivo and in vitro experi-
ment of effects of UTI and TXT on the expression of
human breast cancer cell lines, xenografted tumor, and
insulin-like growth factor receptor 1 (IGF-1R), platelet-
derived growth factor A (PDGFA), nerve growth factor
(NGF).
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1. Materials and methods
1.1 Cell line and animals
Human breast cancer cell line MDA-MB-231 (ER-) was
a generous gift from the Shanghai Institutes for Biologi-
cal Sciences, Chinese Academy of Sciences. The total 95
female BALB/c nu/nu mice aged 4-6 weeks old and
weighing 17-21 g were provided by Chongqing Medical
University Animal Research Center (Production License
No. SCXK [Beijing] 2005-0013; Usage Permission No.
SYX [Chongqing] 2007-0001).
1.2 Major reagents and apparatus
UTI was a generous gift from Techpool Bio-Pharma
(Guangzhou, China); TXT was a generous gift from
Sanofi-Aventis. The RT-PCR kit was purchased from
TAKARA. Anti-IGF-1R antibody and anti-PDGFA anti-
body were purchased from Bioworld Technology (USA).
Anti-NGF antibody, anti-ki-67 antibody, anti-caspase-3
antibody, anti-JNk-2 (c-Jun N-terminal-kinase-2) anti-
body, and anti-NF-B were purchased from Abcam
Company. CA15-3 monoclonal antibody was purchased
from Zhongshan Goldenbridge Biotechnology (Beijing,
China). A Facsvantage SE flow cytometer was purchased
from BD Company (USA); the Gel Doc XR quantity one
gel image analyzer was purchased from Bio-Rad Com-
pany (Hercules, CA, USA) and the CX40 fluorescent
invert microscope was purchased from Olympus
(Tokyo, Japan).
1.3 Cell culture and nude mice breeding
A female breast cancer patient, aged 72 years, without
chemotherapy and particular previous medical history,
was treated by Breast & Thyroid & Pancreas Surgery in
Second Affiliated Hospital of Chongqing Medical Uni-
versity. A specimen was taken from the patient’s breast,
which had undergone radical mastectomy. The pathol-
ogy results revealed an infiltrating ductal carcinoma;
immunohistochemistry revealed ER (+), PR(++), CerbB-
2(-). The breast carcinoma specimen was sent to the lab
within 2 h and cut into 1-mm3 pieces. The sample was
digested for 12 h in a mixture of 1% collagenase II plus
hyaluronidase at 37°C, the supernatant was discarded,
and the sample without supernatant was centrifuged at
1000 r/min for 5 min. A single breast carcinoma cells
was collected, diluted to a concentration of 105/mL, and
then cultured in RPMI 1640 + 10% fetal bovine serum
culture medium. Trypan blue stain was used to assess
cell viability, and vivid breast carcinoma cells were taken
to descendence. Cell adherence was used repeatedly to
remove cell impurities [6]. Human breast cancer cell
line MDA-MB-231 was cultured in RPMI-1640 medium
plus 10% fetal bovine serum, 100 U/mL penicillin, and
100 mg/L streptomycin at 37°C in an incubator with 5%
CO2 and saturated in a humidity environment. The cul-
tured cells within logarithmic growth were used in this
study. Cell suspensions were prepared by trypsin diges-
tion. Nude mice were kept in a specific pathogen free
environment with a temperature of 22-25°C and 50-65%
humidity. Drinking water, feed, and experimental mate-
rials were disinfected by sterilization, and the rule of
aseptic operation was strictly followed. Our research
reported in the manuscript has been performed with the
approval of Chongqing Medical University ethics
committee.
1.4 Immunocytochemical fluorescent staining
For fluorescent staining, 1 × 105 cultured cells were
planted onto cover glass. The cover glass was removed
when the cells covered 80% of the glass. After being
fixed, the cover glass was 1) used to hatch inactive
endogenous enzyme, 2) treated in 0.1% Triton liquid, 3)
washed within phosphate-buffered saline (PBS), 4) sub-
jected to immunocytochemical and immunofluorescent
staining according to instructions for CA15-3 primary
antibody (1:100) and fluorescein isothiocyanate-marked
secondary antibody (1:100), 5) sealed with glycerine, 6)
inserted into an Olympus CX40 inverted microscope for
observation and recording.
1.5 Grouping and drug administration
1.5.1 Cell experiment
Cells were divided into four groups: 1) the control group
was treated with physiological saline only; 2) the UTI
group was treated with UTI at the concentration of 800
u/mL [5]; 3) the TXT group was treated with TXT at
the concentration (same as the average peak plasma
concentration) of 3.7 μg/mL [7]; and 4) the UTI+TXT
group was treated with UTI and TXT at the same con-
centrations described above. All drugs were prepared 6
h before administration.
1.5.2 Animal experiment
After being harvested, the cell lines washed with PBS
and resuspended in serum-free RPMI-1640 medium.
The cell concentration was adjusted to 1 × 107 cells/mL.
Cells were inoculated subcutaneously into the right arm-
pits of 45 nude mice at 0.2 mL/mouse. 21 days after
inoculation, animals with tumor volumes ≥ 500 mm3
were chosen in the study. A total of 28 animals were
randomly divided into four groups for subsequent intra-
peritoneal injections as follows: 1) The UTI group (n =
7) was injected with UTI at 1600 U/day/mouse for 20
consecutive days [4]; 2) the TXT group (n = 7) was
injected with TXT at 20 mg/kg on days 1, 7, and 14 [7];
3) the UTI+TXT group (n = 7) was injected with UTI
and TXT at dosages of UTI and TXT groups described
in 1.5.1; and 4) the control group (n = 7) was injected
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with an equal volume of saline in 1.5.1 for 20 days. The
animals were sacrificed for sample collection 21 days
after administration. Minimum (D) and maximum (L)
tumor diameters were measured to calculate the tumor
volume (V), drawn the growth curve, and calculate the
tumor inhibition rate. The q was also calculated via
King’s formula (a is the inhibition rate of UTI, b is the
inhibition rate of TXT, and c is the inhibition rate of
group UTI+TXT; q > 1.15 represents a synergistic effect,
1.15 >q > 0.85 represents an additive effect, and q < 0.85
represents an antagonistic effect). The related formulas
are as follows:
1) tumor volume (cm3) = (L2 × D)/2;
2) tumor inhibition rate (%) = [1 -(starting average
tumor volume of treatment group - ending average
tumor volume of treatment group)/(starting average
tumor volume of control group - ending average tumor
volume of control group)] × 100%;
3) q = c/ [(a + b) - a × b].
After being harvested, MDA-MB-231 cells were
washed twice with PBS, and then resuspended in serum-
free RPMI-1640 medium. The cell concentration was
adjusted to 2.5 × 1010 cells/L. Cells were inoculated sub-
cutaneously into the right armpits of 50 nude mice at
0.2 mL/mouse. The method was the same as the experi-
ment described above.
1.6 Detection of cell proliferation by MTT
Cultured cells were inoculated into 96-well plate at 1.5
× 103 cells/well and divided into four groups as
described in 1.5. Cells were cultured for 24, 48, or 72 h
in a 37°C humid environment with 20 μL MTT solution
(5 mg/mL). After another 4 h of culturing at 37°C, the
culture medium was removed, 200 μL dimethyl sulfox-
ide was added to each well, and the plates were incu-
bated for 10 min with shaking. The absorbance of each
well was detected with an enzyme-linked immunosor-
bent assay microplate reader at a wavelength of 570-nm,
and then the growth inhibition rate was calculated. All
experiments were repeated 3 times under the same
conditions.
1.7 Detection of cell apoptosis by flow cytometry
Cells were inoculated into a 25-mL flask and treated
with drugs as described in 1.5 when they covered 80%
of the flask. After being treated for 48 h, cells were
digested by trypsin, collected by centrifuge, resuspended
in an EP tube with PBS, and fixed in 1% polymerisatum.
Before being used in the experiment, the cells were
washed three times in PBS, added Annexin-V/PI stored
in 4°C, stood at room temperature without light for 3
min, and were filtered in 300-mesh filter traps. Flow
cytometry (Facsvantage SE; BD) was used to analyze cell
apoptosis.
1.8 Reverse-transcribed quantitative PCR detection of IGF-
1R, PDGFA, NGF, NF-B, and JNK2 mRNA expression in
primary breast cancer cells and breast cancer cell line
MDA-MB-231
Cells were inoculated into four 75-mL flasks (5 × 105
cells/mL) and cultured for 48 h in RPMI-1640 culture
medium plus 10% fetal bovine serum. After removing
the original medium, cells were treated for 48 h with
drugs as described in 1.5. Total RNA in all experimental
groups was isolated with RNAiso Plus following instruc-
tions. The concentration and purity of isolated total
RNA was measured by ultraviolet spectrophotometry.
The cDNA was then reverse-transcribed according to
the instructions in the reagent kit and amplified via PCR
with b-actin and glyceraldehyde 3-phosphate dehydro-
genase (GAPDH) as inner consults. Primer design soft-
ware Primer 5.0 from Shanghai Biotechnology
(Shanghai, China) was used to design the primer.
The primer sequence was as follows. Up primer of
IGF-1R: 5’TGGAGTGCTGTATGCCTCTGTG-3’, down
primer of IGF-1R: 5’-GTGGACGAACTTATTGG
CGTTG-3’, amplified product: 493 bp. Up primer of
PDGFA: 5’-CCCGCAGTCAGATCCACAGCAT-3’,
down primer of PDGFA: 5’-TTCCCGTGTCCTCTT
CCCGATA-3’, amplified product: 483 bp. Up primer of
NGF: 5’-CCCCCTTCAACAGGACTCAC-3’, down pri-
mer of NGF: 5’-GGTCTTATCCCCAACCCACA-3’,
amplified product: 110 bp. Up primer of NF-B: 5’-
CTTCAGAATGGCAGAAGATGA-3’, down primer of
NF-B: 5’-CACATACATAACGGAAACGAAA-3’,
amplified product: 191 bp. Up primer of JNK2: 5’-
TGCGTCACCCATACATCACT-3’, down primer of
JNK2: 5’-TGCTTCTTTCTTCCCAATCC-3’, amplified
product: 156 bp. Up primer of GAPDH: 5’-ATCAAC
GGGAAACCCATCAC-3’, down primer of GAPDH: 5’-
CGCCAGTAGACTCCACGACAT-3’, amplified product:
98 bp. Up primer of b-actin: 5’-CACCCGCGAGTA-
CAACCTTC-3’, down primer of b-actin: 5’-CCCA-
TACCCACCATCACACC-3’, amplified product: 207 bp.
The reaction conditions were as follows: denaturation at
94°C for 30 s, at 58°C for 30 s, and at 72°C for 1 min,
for a total of 35 cycles. A total of 5 μL test factor and
internal amplified product were separately subjected to
agarose gel electrophoresis and analyzed via the Gel
Doc-XR quantitative analysis system. Cell expression
was represented as the ratio of amplified integrated gene
absorption to internal gene absorption.
1.9 Detection of protein expression in IGF-1R and PDGFA
via western blotting
Cell protein samples in each experimental group were
collected by western cell lysate. Collected protein sam-
ples were 1) expanded by polyacrylamide gel electro-
phoresis; 2) blotted onto polyvinylidene fluoride
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membrane by electroporation; 3) hatched at room tem-
perature for 2 h with anti-IGF-1R (1:500) antibody, anti-
PDGFA (1:500) antibody, or membrane; 4) treated with
horseradish peroxidase and enzyme-labeled secondary
antibody; 5) subjected to color reaction via the enhanced
chemiluminescence hypersensitive chemiluminescence
method. The optical band concentration was analyzed
and recorded with the Gel Analysis System. Detection of
relative protein strength was represented in the ratio of
the optical protein band concentration to the internal
gene b-actin.
1.10 Detection of protein expression in xenografted
tumor tissue in nude mice by immunohistochemistry
(Staining Horseradish Proxidase)
Xenografted tumors from sacrificed nude mice were col-
lected for immunohistochemical analysis. The appear-
ance of brown granules in the cytoplasm was considered
positive for protein. The integrated optical concentration
of slides in each group was analyzed via Image-Pro Plus
6.0.
2. Statistical analysis
All data were analyzed with SPSS 18.0 and represented
as x¯ ± s. A completely randomly designed analysis of
variance was used to compare the data among groups,
and differences of P < 0.05 were considered statistically
significant.
3. Results
3.1 Growth, morphology, and appraisal of breast
carcinoma cells
The cultured breast carcinoma cells showed stable pro-
liferation after 2 weeks by adhering to the wall in long
shuttle shapes, while some interstitial cells showed in
polygon stretching growth, sometimes the cell fragments
and dross covered there. Differential adhesion was used
to remove the interstitial cells and fibroblasts. Breast
carcinoma cells were those whose cell viability reached
90% as detected by trypan blue stain and that achieved
positive results for cytoplasmic glycoprotein in immuno-
cytochemical staining (Figure 1).
3.2 Proliferation of breast carcinoma cells
Primary breast carcinoma cells were treated with UTI,
TXT, or UTI+TXT for 24-72 h, and the results showed
that UTI, TXT, and UTI+TXT significantly inhibited
the proliferation of breast carcinoma cells. These inhibi-
tory effects were statistically significant compared with
the control group (P < 0.05). In addition, the inhibitory
effect was enhanced after extended treatment, which
reveals a time-dependent effect (Figure 2a). UTI, TXT,
and UTI+TXT also significantly inhibited the prolifera-
tion of MDA-MB-231 cells compared with the control
group (P < 0.05), and the inhibitory effect was enhanced
after extended treatment (P < 0.01). The strength of the
inhibitory effects of the treatments was UTI+TXT >
TXT > UTI. All differences were statistically significant
(P < 0.01; Figure 2b).
3.3 Apoptosis rate of breast carcinoma cells
After being treated with UTI, TXT, or UTI+TXT for 48
h, apoptosis rates of primary breast carcinoma cells
were 4.562% ± 0.263, 7.683% ± 0.253, and 10.115% ±
0.123, respectively. Compared with the control group
(3.426% ± 0.156), UTI, TXT, and UTI+TXT significantly
induced the apoptosis of breast carcinoma cells (P <
0.05); the effect on UTI+TXT was strongest (Figure 3).
UTI, TXT, and UTI+TXT also significantly induced the
apoptosis of MDA-MB-231 breast carcinoma cells (P <
0.05), and effect on UTI+TXT was strongest (Figure 4).
3.4 Protein expression of IGF-1R and PDGFA in breast
carcinoma cells
Western blotting showed that after primary breast carci-
noma cells were respectively treated with UTI, TXT, and
UTI+TXT for 48 h, the protein expression of IGF-1R and
PDGFA decreased significantly compared with the control
group (P < 0.05; Figure 5) in the order of UTI+TXT > TXT
> UTI. There are synergetic effects in UTI+TXT, either.
3.5 Gene expression of IGF-1R, PDGFA, NGF, NF-B, and
JNK2 in breast carcinoma cells
After being respectively treated with UTI, TXT and UTI
+TXT for 48h, the gene expression of IGF-1R, PDGFA,
NGF, NF-B, and JNK2 in human breast cancer cells
decreased significantly compared with the control group
Figure 1 Positive expression of primary cultured cell CA15-3
(400×).
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(P < 0.05; Figure 6, Figure 7a, b, c, d, e) in the order of
UTI+TXT > TXT > UTI > control. UTI, TXT, and UTI
+TXT also significantly inhibit the NGF mRNA expres-
sion on MDA-MB-231 breast carcinoma cells compared
with the control group (P < 0.05). However, the differ-
ence in NGF mRNA expression between the TXT and
UTI+TXT groups was not statistical significant (P =
0.055; Figure 7f).
Figure 2 (a). Effect of UTI and TXT on the proliferation of primary (ER+) breast carcinoma cells. (b). Effect of UTI and TXT on the
proliferation of MDA-MB-231 (ER-) breast carcinoma cells.
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3.6 Effects of UTI and TXT on the growth of xenografted
breast tumor in nude mice
A total of 2 mice (1 in the control group and 1 in the
UTI group) died after the drug treatment because of
tumor-associated extreme consumption and cachexia.
The growth curve of primary breast transplanted
tumors showed that the average tumor volume of the
mice in the control and UTI groups was not markedly
Figure 3 Effect of UTI and TXT on the apoptosis rate of primary breast carcinoma cells.
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reduced; however, UTI delays the increase in trans-
planted tumor volume (P < 0.05). In contrast, the aver-
age tumor volume in animals in the TXT and UTI
+TXT groups gradually reduced over time after 11 d
in the order of UTI+TXT > TXT (P < 0.05). King’s
formula was q = 1.088, implying an additive inhibitory
effect of UTI and TXT on the growth of transplanted
breast cancer in nude mice (Figure 8a). The growth
Figure 4 Effect of UTI and TXT on the apoptosis rate of MDA-MB-231 breast carcinoma cells.
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curve of the MDA-MB-231 transplanted tumors was
the same (Figure 8b).
3.7 Effects of UTI and TXT protein expression of PAFR,
PDGFA, IGF-1R, NGF, NF-B, and JNk-2 in xenografted
tumors
Immunohistochemistry showed that UTI, TXT, and UTI
+TXT significantly inhibited the protein expression of
PDGFA, NGF, and IGF-1R compared with the control
group (P < 0.05). The inhibitory effect of UTI+TXT was
strongest. The expression of ki-67, JNk-2, and NF-B
was reduced in the UTI, TXT, and UTI+TXT groups;
however, the protein expression of caspase-3 increased
significantly, and this effect was strongest for UTI+TXT
(P < 0.05;Figure 9, 10, 11).
4. Discussion
Primary culture is the first culture after obtaining tissue
from donor. The advantage of primary culture is that most
of the cell still displays the biological characteristics of the
in vivo cells. The result from Koechli [8] reported that an
in vitro experimental result has good correlation with in
vivo chemotherapeutical reactions (sensitivity = 90%, spe-
cificity = 86%). Hence, the primary culture method is sui-
table for investigating differences in the biological features
of tumor cells. Proliferation inhibition and apoptosis are
key factors in tumor treatment. In the present experiment,
the proliferation of primary (ER+) and MDA-MB-231
(ER-) breast carcinoma cells are inhibited in a time-depen-
dent manner. In addition, apoptosis of breast carcinoma
cells increase. The anti-tumor effect of UTI+TXT was
stronger than when UTI or TXT was used alone. Thus,
UTI can enhance the anti-tumor effect of TXT. ki-67 anti-
gen is a nuclear antigen related to cell proliferation; its
function is related to chromosomes and cell karyokinesis
[9]. ki-67 can reflect the proliferation viability of carci-
noma cells because it is strongly related to the develop-
ment, metastasis, and prognosis of malignant tumor [10].
Caspase-3 is the most important executor of apoptosis in
the caspase family. Cell apoptosis can be inhibited by inhi-
biting the viability and functioning of caspase-3. Activated
caspase-3 has a strong capacity to induce apoptosis of
tumor cells; the increasing expression level suggests the
cell apoptosis [11]. In this experiment, the decrease in ki-
67 expression and increase in caspase-3 expression in
xenografted tumor is further proof of the ability of these
proteins to inhibit proliferation and increase apoptosis of
tumor cells.
JNk is a member of the mitogen-activated protein
kinase (MAPK) family. JNK2 gene is located on 5q35
and mainly mediates in vitro stimulation signals, such as
virus, toxin, cytokine, and environmental stimulation
signals [12].
IGF-1R is highly expressed in many kinds of tumors
and closely related to tumor occurrence, development,
and apoptosis. Overexpression of IGF-1R can promote
the growth of breast carcinoma cells, and it might be
related to induction of tumor apoptosis and stimulation
of an immune reaction to remove residual carcinoma
cells [13]. Upon being combined with corresponding
ligands, IGF-1R inactivates the BAD protein, a member
of the bcl family, by activating the PI3K/Akt or Ras/Raf-
1/MAPK family to avoid apoptosis. Meanwhile, IGF-1R
can activate NF-B viability and induce cell proliferation
[14,15].
PDGF is a group of peptide growth factors encoded
by the primary cancer gene c-sis. When PDGF com-
bines with corresponding acceptors (PDGFR), it can
phosphorylate cell membrane protein and induce cell
malignant transformation. PDGFA/PDGFR-a functions
via autocrine and paracrine signals to stimulate inter-
stitial hyperplasia and indirectly promote tumor
growth; in addition, it can promote cell proliferation
by strengthening the response of IGF-1 [16,17]. PDGF
can improve PI3K activity, stimulate the
Figure 5 Effect of UTI and TXT on protein expression levels of
IGF-1R and PDGFA in primary breast carcinoma cells.
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phosphorylation of MAPK and AKT, increase degrada-
tion of extracellular proteins, upregulate MMP-2/9
expression, promote cell proliferation, and avoid apop-
tosis [18,19].
NGF is a pluripotent polypeptide growth factor, strong
mitogen related to the proliferation, invasion, and vascu-
larization of breast carcinoma cells [20,21]. Dolle et al.
showed that breast carcinoma cells can produce and
overexpress NGF [22]. Combined with acceptors in the
breast carcinoma cell membrane, NGF can induce pro-
liferation and inhibit apoptosis of breast carcinoma cells
via a series of cascade reactions and signal transduction,
then stimulate breast carcinoma cells to produce more
NGF, forming a malignant autocrine loop. MCF-7, T47-
D, BT-20, and MDA-MB-231 breast carcinoma cells
secrete NGF and express NGFR; when NGF combines
Figure 6 Line of gene expression in IGF-1R/b-actin, NGF/GAPDH, PDGFA/b-actin, NF-kB/GAPDH, JNk2/GAPDH. Note: M): DL1000 Marker;
A): control group; B): UTI group; C): TXT group; D): UTI+TXT group.
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Figure 7 (a). Gene expression of IGF-1R in primary breast carcinoma cells. (b). Gene expression of PDGFA in primary breast carcinoma
cells. (c). Effect of UTI and TXT on gene expression of NGF in primary breast carcinoma cells. (d). Effect of UTI and TXT on gene expression of
NF-B in primary breast carcinoma cells. (e). Effect of UTI and TXT on gene expression of JNk-2 in primary breast carcinoma cells. (f). Effect of UTI
and TXT on gene expression of NGF in MDA-MB-231 breast carcinoma cells.
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with TrkA, an intracellular signal is sent via p21ras by
phosphorylation and the ras-MAPK signal pathway is
stimulated to influence gene transcription, translation
and mediate cell growth [23,24]. In the present
experiment, we find that UTI and TXT inhibit gene and
protein expression of IGF-1R, PDGFA, NGF, NF-B,
and JNk-2 in breast carcinoma cells and the effect of
UTI+TXT is strongest.
Figure 8 (a). Growth curve for primary breast cancer cell xenografted tumors. (b). Growth curve for MDA-MB-231 breast cancer cell
xenografted tumors.
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In conclusion, this experiment demonstrates that UTI
and TXT inhibit proliferation of breast cancer cells and
growth of xenografted breast tumors, induce apoptosis
of breast cancer cells. UTI and TXT down-regulate the
expression of mRNA and protein of IGF-1R, PDGFA,
NGF, NF-B, and JNk-2 in breast cancer cells and xeno-
grafted breast tumors. The effect of UTI+TXT is stron-
gest. This suggests that UTI and TXT have synergistic
effects. The mechanism might be related to a decrease
in the signal transduction of JNk-2 and NF-B, and
then the expression of IGF-1R, PDGFA, NGF.
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